Glucopath
State Program

CalRx Insulin Glargine (California)

Who it is for

Any California resident; no eligibility requirements; no application needed

What it covers

Biosimilar insulin glargine for ≤$55 per 5-pack pens at CA pharmacies; ask pharmacist to substitute

What it costs you

Estimated using comparable biosimilar discount rates (Rezvoglar at ~78% off Lantus) as a proxy, since a direct CalRx savings figure was not independently confirmed.

Products covered

Lantus

Eligibility

  • Any California resident; no eligibility requirements; no application needed
  • Insurance status: uninsured, private, marketplace, medicare, medicaid, va, tricare
  • Diabetes type: any
  • Available in: CA

What you will need to apply

Use our universal document checklist.

Official links

Glucopath is not medical or legal advice. Program rules change. Verify details with the program before you apply, and talk to your healthcare provider about your treatment.